Polycystin Antibodies

Santa Cruz Biotechnology features a diverse variety of Polycystin monoclonal antibodies for studying polycystins, integral membrane proteins critical for kidney function and cellular signaling. Polycystin monoclonal antibodies are compatible with multiple research techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Polycystins play a significant role in regulating cell proliferation, differentiation, and maintaining renal tubular architecture. Dysregulation of polycystin function is associated with polycystic kidney disease (PKD), a genetic disorder that leads to cyst formation in the kidneys and can result in renal failure. Understanding polycystin mechanisms is essential for developing therapeutic strategies for PKD and related conditions. Polycystin research has revealed important insights into kidney development and disease progression. Ongoing studies continue to uncover new functions and regulatory pathways involving polycystins in cellular homeostasis. Current research focuses on identifying potential therapeutic targets for PKD treatment through detailed analysis of polycystin signaling pathways. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of polycystins and their role in kidney health and disease.